Medpace Holdings Inc
For the period ended Sep 30, 2024. Filed Oct 22, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended September 30, 2024, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
-26-
| Action | Date | Trading Arrangement | Total Shares to be Purchased or Sold | Duration/Expiration Date | ||
| Rule 10b5-1* | Non-Rule 10b5-1** | |||||
|---|---|---|---|---|---|---|
| Robert O. Kraft, Director | Adopt | August 22, 2024 [1] | X | Up to 8,127 shares to be sold | August 28, 2024 | |
- Intended to satisfy the affirmative defense of Rule 10b5-1(c).
** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
[1] On August 22, 2024, Robert O. Kraft placed a limit order to sell up to 8,127 shares issued to him pursuant to his contemporaneous exercise of stock options.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.